Pre-Screening Study to Identify MTAP Loss in Advanced Solid Tumors or Lymphoma
Clinical trial NCT03361358 · COMPLETED
Trial details
- NCT number
- NCT03361358
- Sponsor
- Agios Pharmaceuticals, Inc.
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2018-03-01
- Primary completion
- 2019-09-30
- Enrollment
- 44
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.